New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment

Document Type

Article

Publication Date

2017

Publisher's Statement

The original material can be found here: https://doi.org/10.1177/0897190016632128

Link to Full Text

Share

COinS